AI-powered communications provider Hyro has raised $45m in a strategic growth funding round led by Healthier Capital for expediting the adoption of AI agents in healthcare.

The round received support from Define Ventures, Norwest, existing investors, and new participation from ServiceNow Ventures and Bon Secours Mercy Health.

Hyro's total funding now stands at $95m, with the latest raise arriving ten months after the company’s previous round.

With this investment, the company will accelerate the development of its AI agents for clinical, administrative, and operational functions in healthcare.

Hyro’s platform is currently used at scale at more than 45 health systems, including recent partners Piedmont Healthcare, Prisma Health, Tampa General Hospital and Sutter Health.

The solution is actively utilised by more than 30 million US patients through voice and chat channels, with increasing uptake by health plans and mid-sized clinic and specialist groups.

Hyro has recently introduced Proactive Px to extend its platform’s capabilities for bi-directional patient communication and anticipatory engagement.

Hyro CEO and co-founder Israel Krush said: “After another ten months of strong execution, landing new enterprise customers and expanding relationships with existing ones, we decided to bring on additional capital to further our mission of improving patient access to care and driving operational excellence for health systems.

“There are plenty of impressive demos in the market, but what healthcare organisations need are AI agents that are patient-ready and enterprise-ready today, designed around proven real-world workflows and best practices, deeply interoperable with EMR systems like Epic, and reinforced with robust safeguards.

“With support from both new strategic investors and long-time partners, we’re well-positioned to expand across new specialties and segments throughout the healthcare ecosystem.”